Ozempic Reducing Heart Disease in Non Diabetics: SELECT Outcomes Trial

from Dr Alo Show · host Cardiologist & Personal Trainer Dr. Alo

Ozempic, Wegovy, Semaglutide are reducing heart disease in non diabetics! The SELECT outcomes trial has demonstrated a 20% reduction in cardiovascular outcomes in non diabetics. https://dralo.net/links 

Episode metadata supplied by the publisher feed · Published Nov 17, 2023

Embed this episode

Attribution link and audio player

Ready to play

Ozempic Reducing Heart Disease in Non Diabetics: SELECT Outcomes Trial

0:00 8:44

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Dr Alo Show?

This episode is 8 minutes long.

When was this Dr Alo Show episode published?

This episode was published on November 17, 2023.

Can I download this Dr Alo Show episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!